Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Researchers from Kumamoto University (Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular damage, inflammation and fibrosis. Metformin's mechanism is different from existing therapeutics which only treat symptoms, such as the blood pressure […]

Read more

Biomarkers in the blood can predict severe outcomes in COVID-19 patients

When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. New Yale research could help them identify important early clues. In a recent study, researchers report that a series […]

Read more

Increasing glutathione levels lowers Alzheimer’s pathology and improves cognitive decline

Australian researchers have shown that a dietary supplement that increases the levels of a powerful antioxidant in the brain may represent a novel strategy for the treatment and/or prevention of cognitive impairment and debilitating neurodegenerative diseases such as Alzheimer’s disease. Findings of the study were recently published in Neurochemistry International. A team of researchers from UNSW Sydney’s Centre for Healthy […]

Read more

What is Cutaneous T-Cell Lymphoma?

Cutaneous T-cell lymphomas are a group of T-cell related cancers that mainly affect the skin. There are many different treatment options available for Cutaneous T-cell lymphomas with varying degrees of success. Skip to Cutaneous T-cell lymphoma Pathogenesis and pathophysiology of cutaneous T-cell lymphoma Screening and diagnosis for cutaneous T-cell lymphoma Treatments for cutaneous T-cell lymphoma Cutaneous T-cell lymphoma. Image Credit: […]

Read more